The standard dilution is 23 mL bacteriostatic water per 5 mg peptide vial, yielding a 1.672.5 mg/mL solution suitable for subcutaneous administration in research models
The peptide is stable in gastric acid, which makes oral administration viable for gut-targeted applications, a property that distinguishes it from many other therapeutic peptides that degrade before reaching target tissue
Some peptides are FDA approved for specific medical uses, but many of the peptides discussed for general inflammation, healing, and brain health remain investigational or are limited to compounding under shifting rules
But it makes the screening non-negotiable
May 2022;8(3):1025-1035
Focus on these factors instead: Quality of the peptide (purity, proper storage, legitimate sourcing) Consistency of dosing (daily administration at similar times) Route of administration (subcutaneous is most common and effective for most uses) Adequate dosage (underdosing is more common than overdosing) Supporting recovery factors (sleep, nutrition, stress management) Ive seen people get lackluster results from improperly prepared peptides dosed perfectly, and exceptional results from high-quality BPC-157 dosed once daily
